Latest updates on cell therapy, medical tourism, and healthcare policy for international patients. AI-curated with sources cited.
China's transcatheter aortic valve replacement (TAVR) is developing rapidly, with the domestic annual procedure volume reaching 12,000 cases in 2023, a year-on-year increase of 40%, and it is expected to exceed 15,000 cases in 2024.
Read articleSeveral top-tier hospitals in Shanghai have recently introduced MRI-guided focused ultrasound (MRgFUS) technology for the non-invasive treatment of uterine fibroids.
Read articleDigital therapeutics are moving from concept validation to large-scale application, particularly showing immense potential in the field of chronic disease management.
Read articleA latest clinical study published in the *New England Journal of Medicine* demonstrates breakthrough progress in the treatment of non-small cell lung cancer and melanoma using immune checkpoint inhibitors combined with targeted drugs.
Read articleIn China, gene testing technology is rapidly integrating into oncology treatment processes, advancing precision medicine from concept to clinical practice.
Read articleUniportal video-assisted thoracoscopic surgery (Uniportal VATS) has recently achieved significant progress in the field of thoracic surgery, performing complex procedures such as lobectomy and radical esophagectomy through a single incision of approximately 3-4 centimeters, further reducing trauma c
Read articleChina's corneal transplant field has recently seen dual benefits: on one hand, a new generation of bioengineered corneas (such as acellular porcine corneal stroma) has demonstrated comparable efficacy to traditional donor corneas in clinical trials, with a 12-month graft survival rate of 92%; on the
Read articleRecently, a multicenter study published in the *Journal of Clinical Oncology* demonstrated that liquid biopsy-based multi-cancer early detection (MCED) technology can identify over 50 cancer types in asymptomatic individuals, with an overall sensitivity of 51.5% and specificity of 99.5%.
Read articleThe Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Tianjin), recently released its 2025 clinical data on autologous hematopoietic stem cell transplantation (ASCT): For multiple myeloma patients, after adopting the modified BuMel (busulfan combined with melp
Read articleGet the latest medical insights and healthcare news delivered to your inbox.
